Rangeley Capital »

Avidity Biosciences Ord shares owned by Rangeley Capital

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.9M 54k 72.13

More positions owned by Rangeley Capital

Warner Bros Discovery Com Ser A Call Option (WBD)
Golden Entmt (GDEN)
Calumet (CLMT)
Prothena Corp SHS (PRTA)
Yext (YEXT)
Arvinas Ord (ARVN)
Arbutus Biopharma (ABUS)
Avidity Biosciences Ord (RNA)
Repare Therapeutics Ord
Kennedy-Wilson Holdings (KW)
Seaport Entmt Group Common Stock (SEG)
Delek Us Holdings (DK)
Berto Acquisition Corp Ord Shs (TACO)
Grindr (GRND)
Plymouth Indl Reit

View all positions for Rangeley Capital

Top funds holding Avidity Biosciences Ord

FMR
Henderson Group
Vanguard Group
BlackRock
Wellington Management Company
RA Capital Management
venBio Select Advisor
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Norges Bank Investment Management
Bellevue Group
Glazer Capital
UBS Group
Susquehanna International

View all funds holding Avidity Biosciences Ord